Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement
CompletedPhase 2, Phase 3NCT01188551
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a study to compare intranasal dexmedetomidine to intranasal fentanyl following anesthesia induction in patients undergoing myringotomy and placement of pressure equalization (PE) tubes in providing analgesia and smoothing emergence from general anesthesia.
Study details
- Official title
- Pain Management Following Myringotomy and Tube Placement: Intranasal Dexmedetomidine Versus Fentanyl
- Conditions
- Chronic Otitis Media
- Interventions
- Sponsor
- Nationwide Children's Hospital
- Start date
- 2011-01
- Primary completion
- 2012-04
- Sex
- All
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * functional status as assigned by the American Society of Anesthesiology (ASA) classification of I or II (no or minimal co-morbid disease) * patients scheduled for placement of bilateral myringotomy tubes Exclusion Criteria: * history of allergy to either dexmedetomidine or fentanyl * concomitant use of medications which may exaggerate the HR response of dexmedetomidine including digoxin or β-adrenergic antagonists.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01188551